Table 3.

Fluorescent Intensity and complication rates by perfusion pattern.^*

Fluorescent Intensity by Perfusion Pattern
	All patients	V1 (n=27)	V2 (n=25)	V3 (n=27)	p
Post-NSM, breast overall	62.9 ± 26.1 %	64.0 ± 23.6%	62.2 ± 22.8%	62.5 ± 31.7%	0.96
Post-recon, breast overall	31.9 ± 14.4%	32.5 ± 14.0%	31.3 ± 9.0%	31.9 ± 18.5%	0.96
Post-NSM, nipple	33.0 ± 26.7%	34.2 ± 23.3%	36.3 ± 24.1%	28.9 ± 24%	0.6
Post recon, nipple	25.7 ± 23.07%	26.4 ± 20.2%	26.1 ± 22.5%	24.6 ± 26.8%	0.95
Post-NSM, inferior	59.8 ± 32.3%	58.3 ± 30.4%	65.5 ± 32.9%	56.1 ± 34.1%	0.6
Post-recon, inferior	26.5 ± 19.4%	26.8 ± 15.6%	28.6 ± 22.4%	24.2 ± 20.3%	0.7
Post-NSM, lateral	74.4 ± 49.0%	75.9 ± 47.5%	85.9 ± 64.8%	63.1 ± 29.0%	0.2
Post-recon, lateral	28.4 ± 20.6%	27.0 ± 20.4%	32.4 ± 19.3%	26.2 ± 22.2%	0.5
Post-NSM, medial	63.3 ± 31.3%	65.6 ± 29.4%	60.7 ± 28.6%	63.5 ± 36.2%	0.9
Post-recon, medial	29.2 ± 18.4%	31.4 ± 16.7%	25.6 ± 16.6%	28.6 ± 21.6%	0.7
Complications by Perfusion Pattern
Any Necrosis	21 (26.5%)	8 (29.6%)	4 (16%)	9 (33.3%)	0.3
Nipple tip necrosis	16 (20.2%)	6 (22.2%)	2 (8%)	8 (29.6%)	0.2
Nipple loss	1 (1.3%)	1 (3.7%)	0	0	1
Flap necrosis requiring excision	8 (10.1%)	4 (14.8%)	3 (12%)	1 (3.7%)	0.4
Infection	8 (10.1%)	3 (11.1%)	3 (12%)	2 (7.4%)	0.9
Hematoma	3 (3.8%)	2 (7.4%)	1 (4%)	0	0.5
Seroma	5 (6.3%)	2 (7.4%)	2 (8%)	1 (3.7%)	0.9
Device malposition	6 (7.6%)	2 (7.4%)	3 (12%)	1 (3.7%)	0.5
Implant exposure	0	0	0	0	1
Wound dehiscence	2 (2.5%)	1 (3.7%)	0	1 (3.7%)	1
Total OR trips	1.6 ± 0.7	1.7 ± 0.7	1.7 ± 0.7	1.3 ± 0.7	0.1
Explant	4 (5.1%)	1 (3.7%)	3 (12%)	0	0.1

^*Values presented as a percentage of the original preoperative perfusion, minus background fluorescence, based on 0-255 unit, 8-bit greyscale.